Preventing perinatal HIV transmission: Zidovudine use during pregnancy

American Family Physician

Volumn 55, Issue 1, 1997, Pages 171-174

  Carmichael, Cynthia ^a,b  

^a Florida AIDS Educ/Training Center   (United States)

^b Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BREAST FEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN; ORAL DRUG ADMINISTRATION; PATIENT COUNSELING; PERINATAL INFECTION; PREGNANCY; REVIEW; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; COUNSELING; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIDOVUDINE;

EID: 0031031495     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Update: AIDS among women - United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:81-4.
2. Update: mortality attributable to HIV infection among persons aged 25-44 years - United States, 1994. MMWR Morb Mortal Wkly Rep 1996;45:121-5.
3. Caldwell MB, Fleming PL, Oxtoby MJ. Estimated number of AIDS orphans in the United States [Letter]. Pediatrics 1992;90:482.
4. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through June 1996. HIV/AIDS Surveillance Report 1996;8(1):11.
5. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep 1995;44(RR-7):1-15.
6. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996;334:1617-23.
7. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA 1996;275:599-605.
8. Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet 1994;343:1464-7.
9. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group. N Engl J Med 1994;331:1173-80.
10. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States. MMWR Morb Mortal Wkly Rep 1995;44:929-33.
11. Ho DD. Time to hit HIV, early and hard [Editorial]. N Engl J Med 1995;333:450-1.
12. Frenkel LM, Wagner LE, Demeter LM, Dewhurst S, Coombs RW, Murante BL, et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis 1995;20:1321-6.
13. Recommendations of the U.S. Public Health Service on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
14. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, et al. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996;276:139-45.
15. Wiznia AA, Crane M, Lambert G, Sansary J, Harris A, Solomon L. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center. JAMA 1996;275:1504-6.
16. Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-50.